📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell. (2019)

First Author: Liu S

Attributed to: The impact of IFTIM3 genetic variation on Influenza virus infection, immune responses and disease outcome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2019.00437

PubMed Identifier: 30941124

Publication URI: http://europepmc.org/abstract/MED/30941124

Type: Journal Article/Review

Volume: 10

Parent Publication: Frontiers in immunology

ISSN: 1664-3224